ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
84,135.27
-1.22%
S&P 500
5,633.07
0.38%
Dow Jones
41,989.96
-0.03%
US Dollar vs Yen
149.8855
0.06%
Brent Oil
74.335
-0.11%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Synta Pharmaceuticals Corp. (MM) (SNTA)

  7. Synta Pharmaceuticals Corp. (MM) (SNTA) ニュース

SNTA

Synta Pharmaceuticals Corp. (MM) (SNTA)

Synta Pharmaceuticals Corp. (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SNTA
日付受信時刻ニュースソース見出しコード企業名
2016/07/3004 : 13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/3002 : 25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2706 : 17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2704 : 38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2306 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2306 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2306 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2306 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2300 : 30GlobeNewswire Inc.Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading Cardiovascular-Metabolic Diseases and NASH CompanyNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2205 : 17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/2105 : 04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/0705 : 28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/07/0120 : 35PR Newswire (US)Why Investors Have These Biotech Stocks on Their Radar? - Synta Pharma, Idera Pharma, Threshold Pharma, and Viking Therapeuti...NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/1421 : 32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0905 : 30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0905 : 28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0905 : 15Business WireSynta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal PharmaceuticalsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0905 : 03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0406 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0305 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0305 : 17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/06/0220 : 00Business WireSynta Pharmaceuticals to Present at Upcoming Investor Conferences in JuneNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
2016/05/2721 : 20PR Newswire (US)Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat BiologicsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:SNTA

最近閲覧した銘柄

EU
BELSG
BEL Small Gross Return
BIT
P1J921
BNP Paribas Issuance
BINA
FORBTC
The Force Token [ForTube]
BITMOT
974408
Eib Tf 2,75% Lg28 Eur
NYSE
CURB
Curbline Properties
BIT
METAJ
Fineco Glob Meta e Games...
FX
MWKZAR
MWK vs ZAR
FX
PHPDKK
PHP vs DKK
BIT
P1CSN2
BNP Paribas Issuance
AMEX
FDHT
Fidelity Digital Health ...
UNSW3
LOOKSETH
LooksRare Token
FX
CLPARS
CLP vs ARS
BOV
I1FF34
International Flavors & ...
BOV
STCH34
Standard Chartered
BOV
PEAB4T
PAR AL BAHIA
Delayed Upgrade Clock
ADVFN Logo
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す